These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 11566043)
21. Role of COX-2 selective inhibitors for prevention and treatment of cancer. Amir M; Agarwal HK Pharmazie; 2005 Aug; 60(8):563-70. PubMed ID: 16124396 [TBL] [Abstract][Full Text] [Related]
22. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice. Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127 [TBL] [Abstract][Full Text] [Related]
23. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy. Church RD; Fleshman JW; McLeod HL Br J Surg; 2003 Sep; 90(9):1055-67. PubMed ID: 12945071 [TBL] [Abstract][Full Text] [Related]
24. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors. Reddy BS; Rao CV J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402 [TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust? Sanborn R; Blanke CD Semin Oncol; 2005 Feb; 32(1):69-75. PubMed ID: 15726508 [TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review. Pruthi RS; Derksen E; Gaston K J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797 [TBL] [Abstract][Full Text] [Related]
27. Cancer prevention: a new era beyond cyclooxygenase-2. Rigas B; Kashfi K J Pharmacol Exp Ther; 2005 Jul; 314(1):1-8. PubMed ID: 15805430 [TBL] [Abstract][Full Text] [Related]
28. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer. Saha D; Pyo H; Choy H Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860 [TBL] [Abstract][Full Text] [Related]
29. COX-2 inhibition as a tool to treat and prevent colorectal cancer. Tuynman JB; Peppelenbosch MP; Richel DJ Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074 [TBL] [Abstract][Full Text] [Related]
30. Rofecoxib (Vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancer. Evans JF Am J Clin Oncol; 2003 Aug; 26(4):S62-5. PubMed ID: 12902858 [TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacology of selective COX-2 inhibitors. Capone ML; Tacconelli S; Sciulli MG; Patrignani P Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704 [TBL] [Abstract][Full Text] [Related]
36. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220 [TBL] [Abstract][Full Text] [Related]
37. Aspirin use and potential mechanisms for colorectal cancer prevention. Williams CS; Smalley W; DuBois RN J Clin Invest; 1997 Sep; 100(6):1325-9. PubMed ID: 9294096 [No Abstract] [Full Text] [Related]
38. [Cyclooxygenase 2 inhibitors and colorectal cancer]. Bernardeau-Mozer M; Chaussade S Bull Cancer; 2004 May; 91 Suppl 2():S89-98. PubMed ID: 15899632 [TBL] [Abstract][Full Text] [Related]
39. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms. Nasir A; Fernandez PM; Chughtai OR; Kaiser HE In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894 [TBL] [Abstract][Full Text] [Related]
40. Celecoxib with chemotherapy in colorectal cancer. Blanke CD Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):17-21. PubMed ID: 12014863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]